Target intelligence / Profile preview

Family with sequence similarity 72 member A (FAM72A)

Target
FAM72A
Molecular classification
Other (mitosis-promoting protein; not a classical receptor, enzyme, ion channel, transporter, or transcription factor)
01

Overview

Family with sequence similarity 72 member A (FAM72A) is a mitosis-promoting protein that plays a critical role in the regulation of the cell cycle, genome integrity, and neural stem cell biology[1][5][9]. FAM72A is highly expressed in cancer cells and acts by interacting with uracil-DNA glycosylase (UNG2), thus participating in DNA base excision repair to prevent mutagenesis[1][3]. Its overexpression is correlated with increased proliferative activity in tumor specimens, suggesting a role in tumorigenesis and its utility as a prognostic cancer biomarker[1]. In addition, FAM72A is reciprocally regulated with Srgap2 by growth and differentiation signals, and is implicated in the balance between neural stem cell proliferation and differentiation[1]. Small molecules, notably withaferin B, have been identified in silico to prevent FAM72A-UNG2 interaction, supporting the potential for targeted cancer therapies[3]. FAM72A may also play a role in regulating cellular reactive oxygen species metabolism[2][6][9], and has been associated with diseases including cancer and autism spectrum disorder, although its role in the latter is less clear[5].

Other names
Protein FAM72AUGENELatent membrane protein 1-induced proteinLMP1-induced proteinLMPIPMGC57827RP11-312O7.1p17Ugene
02

Mechanism of action

Inhibition of FAM72A-UNG2 interaction (by interfering with FAM72A’s protein–protein association that is critical for base excision repair and cell cycle modulation)

03

Biological functions

Cell cycle regulationGenome integrity maintenanceNeural stem cell biology (self-renewal, proliferation, differentiation)DNA repair (base excision repair)Positive regulation of apoptotic processRegulation of cellular reactive oxygen species metabolismCell growth regulation
04

Disease associations

Cancer (glioblastoma, neural-derived malignancies, various tumor specimens)Autism spectrum disorder (less well-established)
05

Safety considerations

Potential challenge: FAM72A is involved in genome stability and cell cycle regulation, so its inhibition may disrupt normal stem cell renewal and DNA repairRisk of off-target effects or impaired neural stem cell function
06

Interacting drugs

Withaferin B
07

Biomarkers

FAM72A expression correlates with cell proliferation markers and cell cycle–driving genes in tumors

Beyond the preview

Go deeper on Family with sequence similarity 72 member A (FAM72A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 72 member A (FAM72A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call